MetLife Investment Management’s Blue Foundry Bancorp BLFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12,749
Closed -$169K 2892
2026
Q1
$169K Hold
12,749
﹤0.01% 2310
2025
Q4
$158K Hold
12,749
﹤0.01% 2389
2025
Q3
$116K Hold
12,749
﹤0.01% 2585
2025
Q2
$122K Hold
12,749
﹤0.01% 2443
2025
Q1
$117K Sell
12,749
-625
-5% -$5.97K ﹤0.01% 2453
2024
Q4
$131K Hold
13,374
﹤0.01% 2506
2024
Q3
$137K Sell
13,374
-2,335
-15% -$24.3K ﹤0.01% 2478
2024
Q2
$142K Buy
15,709
+1,556
+11% +$13.8K ﹤0.01% 2435
2024
Q1
$132K Hold
14,153
﹤0.01% 2408
2023
Q4
$137K Hold
14,153
﹤0.01% 2448
2023
Q3
$118K Hold
14,153
﹤0.01% 2493
2023
Q2
$143K Sell
14,153
-3,874
-21% -$37.3K ﹤0.01% 2475
2023
Q1
$172K Hold
18,027
﹤0.01% 2308
2022
Q4
$232K Hold
18,027
﹤0.01% 2155
2022
Q3
$201K Hold
18,027
﹤0.01% 2300
2022
Q2
$216K Hold
18,027
﹤0.01% 2262
2022
Q1
$244K Buy
18,027
+6,545
+57% +$92.4K ﹤0.01% 2234
2021
Q4
$168K Hold
11,482
﹤0.01% 2167
2021
Q3
$158K Buy
+11,482
New +$154K ﹤0.01% 2228

MetLife Investment Management's BLFY Position: Q2 2026 in Review

MetLife Investment Management sold out of Blue Foundry Bancorp (BLFY) in Q2 2026, closing a stake of 12,749 shares — an estimated $169K sold.

MetLife Investment Management first reported a position in BLFY in Q3 2021 and held it in 19 quarters. The position peaked at $244K in Q1 2022. 0 funds tracked by Wall St. Rank hold BLFY as of Q2 2026.

  • MetLife Investment Management reported no remaining Blue Foundry Bancorp position as of Q2 2026 after selling out during the quarter.
  • MetLife Investment Management sold 12,749 Blue Foundry Bancorp shares in Q2 2026, an estimated $169K.
  • MetLife Investment Management first reported a position in Blue Foundry Bancorp in Q3 2021 and held it in 19 quarters.
  • MetLife Investment Management's Blue Foundry Bancorp position peaked at $244K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Blue Foundry Bancorp as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.